Maria Del Trigo, and Josep Rodés-Cabau Circ Cardiovasc Interv... Maria Del Trigo, and Josep Rodés-Cabau Circ Cardiovasc Interv... Percutaneous Mitral Valve Replacement... Medtronic tra
Trang 1Structural and Valvular interventions 2015-2016
A/Prof Michael Nguyen Fiona Stanley Hospital
Australia
Trang 2Overview
• Mitral valve interventions
• Aortic valve interventions
• Left atrial appendage occlusion
• Heart Failure interventions
• Patent Foramen Ovale closure
Trang 3Mitral Valve Interventions
Trang 5EVEREST 2
Trang 8EVEREST II trial results
Maria Del Trigo, and Josep Rodés-Cabau Circ Cardiovasc
Interv 2015;8:e001943
Trang 10Percutaneous mitral annuloplasty devices
Maria Del Trigo, and Josep Rodés-Cabau Circ Cardiovasc
Interv 2015;8:e001943
Trang 11TITAN 2 : Carillon Mitral Device
Trang 12Percutaneous Mitral Valve
Replacement
Trang 14CardiAQ valve
Ole De Backer et al Circ Cardiovasc Interv 2014;7:400-409
Trang 15Tiara valve
Ole De Backer et al Circ Cardiovasc Interv 2014;7:400-409
Trang 16Tendyne valve
Ole De Backer et al Circ Cardiovasc Interv 2014;7:400-409
Trang 17Medtronic transcatheter mitral valve
Ole De Backer et al Circ Cardiovasc Interv 2014;7:400-409
Trang 18Valtech’s Cardiovalve is a transcatheter mitral valve replacement system designed to be
implanted using the transfemoral route
Ole De Backer et al Circ Cardiovasc Interv 2014;7:400-409
Trang 19HighLife transcatheter mitral valve replacement system
Ole De Backer et al Circ Cardiovasc Interv 2014;7:400-409
Trang 20MitrAssist’s valve-in-valve: a valve that assists the existing valve
Ole De Backer et al Circ Cardiovasc Interv 2014;7:400-409
Trang 21TAVR
Trang 23TAVR outcomes
Trang 24US outcomes
Trang 25Partners 2 – Intermediate risk (STS 4% to 8%)
Trang 26Left Atrial Appendage Occlusion
Trang 28PROTECT-AF:
Primary Efficacy Endpoint
Trang 30Structural interventions for HF
Trang 31The left atrial pressure monitoring system
Maria Del Trigo, and Josep Rodés-Cabau Circ Cardiovasc
Interv 2015;8:e001943
Trang 32The pulmonary artery pressure monitoring system
Maria Del Trigo, and Josep Rodés-Cabau Circ Cardiovasc
Interv 2015;8:e001943
Trang 33Left-to-right interatrial shunt devices
Maria Del Trigo, and Josep Rodés-Cabau Circ Cardiovasc
Interv 2015;8:e001943
Trang 34The parachute device
Maria Del Trigo, and Josep Rodés-Cabau Circ Cardiovasc
Interv 2015;8:e001943
Trang 39PFO Occlusion
Trang 40RESPECT - Extend
Trang 44Conclusion
• Structural Interventions are rapidly increasing as a
fundamental treatment option for multiple areas of
cardiovascular disease
• We should embrace these technological advancements but should make sure that comprehensive research to assess safety and long-term efficacy of these
procedures is undertaken
• Dedicated training programs should be developed so that the best expertise can be achieved for our patients
Trang 45The Future is Exciting!